Drug repurposing using transcriptome sequencing and virtual drug screening in a patient with glioblastoma
Conclusions In conclusion, we identified novel small molecules via a drug repurposing approach that could be effectively used for personalized glioblastoma therapy especially for patients carrying BRAF47-438del and PIK3R1-G376R mutations.
Source: Investigational New Drugs - Category: Drugs & Pharmacology Source Type: research
More News: Brain | Brain Cancers | Brain Tumor | Cancer & Oncology | Chemistry | Databases & Libraries | Drugs & Pharmacology | Investigational New Drugs | Neurology | Zinc